Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Selenophosphate synthetase 1 pseudogene 6 (SEPHS1P6) is a processed human pseudogene related to the selenophosphate synthetase 1 gene. Pseudogenes such as SEPHS1P6 are generally formed through retrotransposition or gene duplication events that render them nonfunctional. While some pseudogenes may be transcribed and can potentially act as regulatory RNAs (for example, as microRNA sponges or inhibitors), SEPHS1P6 has not been experimentally demonstrated to have a role in any physiological or pathological process, nor is it considered a target for drug development or a known disease biomarker. SEPHS1P6 is not a misspelled entry, but it is incorrect as a target for therapeutic intervention or protein-level functional study due to its pseudogene status. There is no structured data regarding functional protein product, drug interactions, or disease involvement for SEPHS1P6.
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Selenophosphate synthetase 1 pseudogene 6 (SEPHS1P6).